136 related articles for article (PubMed ID: 30704352)
1. Chronic active Epstein-Barr virus infection: a bi-faceted disease with inflammatory and neoplastic elements.
Arai A
Immunol Med; 2018 Dec; 41(4):162-169. PubMed ID: 30704352
[TBL] [Abstract][Full Text] [Related]
2. Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development.
Arai A
Front Pediatr; 2019; 7():14. PubMed ID: 30805320
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features of adult-onset chronic active Epstein-Barr virus infection].
Kawamoto K; Miyoshi H; Seto M; Kimura H; Ohshima K
Rinsho Ketsueki; 2019; 60(8):944-952. PubMed ID: 31484894
[TBL] [Abstract][Full Text] [Related]
5. STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target.
Onozawa E; Shibayama H; Takada H; Imadome KI; Aoki S; Yoshimori M; Shimizu N; Fujiwara S; Koyama T; Miura O; Arai A
Oncotarget; 2018 Jul; 9(57):31077-31089. PubMed ID: 30123428
[TBL] [Abstract][Full Text] [Related]
6. [The road to treating chronic active Epstein-Barr viral infection].
Arai A
Rinsho Ketsueki; 2021; 62(7):835-845. PubMed ID: 34349069
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders.
Sawada A; Inoue M
Front Pediatr; 2018; 6():334. PubMed ID: 30460216
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report.
Roliński J; Grywalska E; Pyzik A; Dzik M; Opoka-Winiarska V; Surdacka A; Maj M; Burdan F; Pirożyński M; Grabarczyk P; Starosławska E
BMC Infect Dis; 2018 Apr; 18(1):190. PubMed ID: 29678144
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
10. Updated guidelines for chronic active Epstein-Barr virus disease.
Kawada JI; Ito Y; Ohshima K; Yamada M; Kataoka S; Muramatsu H; Sawada A; Wada T; Imadome KI; Arai A; Iwatsuki K; Ohga S; Kimura H;
Int J Hematol; 2023 Nov; 118(5):568-576. PubMed ID: 37728704
[TBL] [Abstract][Full Text] [Related]
11. EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.
Takada H; Imadome KI; Shibayama H; Yoshimori M; Wang L; Saitoh Y; Uota S; Yamaoka S; Koyama T; Shimizu N; Yamamoto K; Fujiwara S; Miura O; Arai A
PLoS One; 2017; 12(3):e0174136. PubMed ID: 28346502
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
13. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
14. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Kimura H
Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
Park S; Ko YH
J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus-Associated γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic
Tanita K; Hoshino A; Imadome KI; Kamiya T; Inoue K; Okano T; Yeh TW; Yanagimachi M; Shiraishi A; Ishimura M; Schober T; Rohlfs M; Takagi M; Imai K; Takada H; Ohga S; Klein C; Morio T; Kanegane H
Front Pediatr; 2019; 7():15. PubMed ID: 30778380
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
19. Chronic Active Epstein-Barr Virus Disease.
Kimura H; Cohen JI
Front Immunol; 2017; 8():1867. PubMed ID: 29375552
[TBL] [Abstract][Full Text] [Related]
20. EBV in T-/NK-Cell Tumorigenesis.
Kimura H
Adv Exp Med Biol; 2018; 1045():459-475. PubMed ID: 29896680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
